RBC Optimistic on Regeneron Following Lower Sales by Novartis' Lucentis
April 24, 2014 at 16:31 PM EDT
RBC Capital Markets analyst Adnan Butt is optimistic on shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) following lower sales ...